Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Welltower (HCN) Share Price

News coverage about Welltower (NYSE:HCN) has trended somewhat positive on Wednesday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Welltower earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave news articles about the real estate investment trust an impact score of 48.0426617952808 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the media stories that may have impacted Accern Sentiment’s analysis:

Several equities analysts recently issued reports on HCN shares. Capital One Financial upgraded shares of Welltower from an “equal weight” rating to an “overweight” rating in a research report on Wednesday, November 8th. Stephens set a $70.00 price target on shares of Welltower and gave the company a “buy” rating in a research report on Friday, January 12th. ValuEngine upgraded shares of Welltower from a “hold” rating to a “buy” rating in a research report on Saturday, January 13th. BMO Capital Markets set a $57.00 price target on shares of Welltower and gave the company a “sell” rating in a research report on Monday, January 15th. Finally, Mizuho reissued a “hold” rating and set a $67.00 price objective on shares of Welltower in a research note on Monday, December 11th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $71.62.

Shares of Welltower (HCN) traded down $1.01 during midday trading on Wednesday, hitting $54.07. 799,020 shares of the stock traded hands, compared to its average volume of 2,825,510. The company has a market capitalization of $20,400.00, a P/E ratio of 47.19, a PEG ratio of 3.79 and a beta of 0.17. Welltower has a 52-week low of $53.00 and a 52-week high of $78.17. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.79.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 21st. Stockholders of record on Tuesday, February 13th will be paid a $0.87 dividend. The ex-dividend date of this dividend is Monday, February 12th. This represents a $3.48 annualized dividend and a dividend yield of 6.44%. Welltower’s dividend payout ratio is presently 305.26%.

In related news, Director Gary Whitelaw acquired 1,420 shares of the firm’s stock in a transaction dated Tuesday, November 21st. The stock was purchased at an average cost of $68.39 per share, with a total value of $97,113.80. Following the completion of the acquisition, the director now directly owns 1,420 shares of the company’s stock, valued at $97,113.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.19% of the company’s stock.

WARNING: This piece of content was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at

Welltower Company Profile

Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.

Insider Buying and Selling by Quarter for Welltower (NYSE:HCN)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with's FREE daily email newsletter.

Leave a Reply